Suramin
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101688This classification denotes an angiogenesis activator inhibitor with the molecular formula C51H40N6O23S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6032D45BEM, chemically known as 1,3,5-naphthylenetrisulfonic acid, 8,8-(ureylenebis(m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino))di- but generally known as suramin, which bears US NIH Compound Identifier 5361. European Medicines Agency schedules Suramin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04651MIG. SURAMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, SURAMIN remains the US FDA Preferred Term for this commodity. Suramin bears US NLM identifiers UMLS ID C0038880 and NCI Concept Code C853. SMILES: S(=O)(=O)(O)C1C2C(C(S(=O)(=O)O)CCC2NC(=O)C2CC(NC(=O)C3CC(NC(=O)NC4CC(C(=O)NC5CC(C(=O)NC6C7C(C(S(=O)(=O)O)CC6)CC(S(=O)(=O)O)CC7S(=O)(=O)O)CCC5C)CCC4)CCC3)C(CC2)C)CC(S(=O)(=O)O)C1.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.